 |
 |

Fetal Risk Associated With Rubella Vaccine
Stephen R. Preblud, MD;
Harrison C. Stetler, MD;
John A. Frank, Jr, MD;
Wayne L. Greaves, MD;
Alan R. Hinman, MD;
Kenneth L. Herrmann, MD
JAMA. 1981;246(13):1413-1417.
Abstract
Ninety-four susceptible women received either Cendehill or HPV-77 rubella vaccine. All gave birth to healthy infants. Seventeen susceptible women received the RA 27/3 vaccine. All their infants were free of abnormalities compatible with congenital rubella, as were 54 born to mothers of unknown immune status at the time of RA 27/3 vaccination and those later found to be immune. An additional susceptible woman received an unknown strain of vaccine; she also had a healthy infant. The risk of severe congenital malformations after rubella vaccination is low. In our 112 cases, the maximum risk was approximately 3%. Concern about the potential adverse effects of rubella vaccine on the fetus should not interfere with vaccination of women of childbearing age. However, since the actual risk may not be zero, women known to be pregnant should not be vaccinated, and conception should be avoided for three months after vaccination.
(JAMA 1981;246:1413-1417)
Author Affiliations
From the Immunization Division, Center for Prevention Services (Drs Preblud, Stetler, Frank, Greaves, and Hinman), and the Perinatal Virology Branch, Virology Division, Center for Infectious Diseases (Dr Herrmann), US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Atlanta. Dr Preblud is now with The Children's Hospital of Philadelphia. Dr Frank is now with Duke University Medical Center, Durham, NC.
Footnotes
Presented in part at the 20th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, Sept 23, 1980.
Reprint requests to Centers for Disease Control, 1600 Clifton Rd NE, Atlanta, GA 30333 (Dr Hinman).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Rubella Vaccination during Pregnancy --United States, 1971-1988
JAMA 1989;261:3374-3383.
Leads From the MMWR
JAMA 1987;258:751-757.
Leads from the MMWR
JAMA 1986;255:2861-2876.
Some Current Issues Relating to Rubella Vaccine
Preblud
JAMA 1985;254:253-256.
ABSTRACT
Rubella Prevention: Recommendation of the Immunization Practices Advisory Committee
ANN INTERN MED 1984;101:505-513.
ABSTRACT
Leads from the MMWR
JAMA 1983;250:1383-1384.
If Nothing Goes Wrong, Is Everything All Right? Interpreting Zero Numerators
Hanley and Lippman-Hand
JAMA 1983;249:1743-1745.
ABSTRACT
Prevention of Rubella Transmission in Medical Facilities
Greaves et al.
JAMA 1982;248:861-864.
ABSTRACT
Congenital Rubella Syndrome: A Continuing Problem
Orenstein and Greaves
JAMA 1982;247:1174-1175.
ABSTRACT
|